lundi 29 février 2016

Valeant CEO Pearson returns to work, but shares slide again anyway

Valeant Michael Pearson

Shares of Valeant Pharmaceuticals plunged in premarket trading, amid ongoing turmoil over the embattled drugmaker's delayed financial results and its leader's health.

0 commentaires:

Enregistrer un commentaire